Background:I was reading something about PawPaw versus Soursop,
for cancer, (looked up Soursop to see its constituents),and came across a
factoid about a population in Guadaloupe, who ate Soursop often, and
had elevated instances of supranuclear palsy and Parkinson’s disease…
I know that Soursop is high in Potassium, which lowers blood pressure…
I know that traumatic brain injury lowers blood pressure(raises Potassium)…
I know that Parkinson’s is related to brain injury…
I theorized then, that raising blood pressure would be beneficial to Parkinson’s disease…
I know that Taurine raises blood pressure…
I looked for studies to confirm that Taurine helps with Parkinson’s disease…
Here(begin at word “Start”) are some of the studies, and notes, I made in my journey to come to this conclusion-that Taurine is beneficial to Parkinson’s disease…
Note: My analysis of what happens is:
Traumatic brain injury causes a fast loss of “Aurum/Cobalamin/epinephrine” from the Medulla Oblongata at the back of the head, which controls the heart…
The substance then excreted at the time of injury, travels down the body…
This excreted substance may end up in the Substantia Nigra/Hypothalamus region, causing a raise in serotonin…
The raise in Serontin, causes tremors, and muscle rigidity…
Doctors have been treating the elevated serotonin, by lowering that with dopamine…
But the causative factor, the injury, which initially lowered Epinephrine/Aurum/Cobalt/B12 in the heart and Medulla Oblongata, is not addressed…
By raising B12, using Taurine supplements, you can address the initial causative factor…
Beta-Agonists raise blood pressure/epiniphrine/Aurum/Cobalamin…(which would also have use for Parkinson’s)…
brain lesions supra nuclear palsy/parkinsons
beta agonists are aurum
beta agonists cause tremor
high blood pressure causes tremor
traumatic brain injury and hypokalemia (high blood pressure?)-tbi causing release of aurum to body?
Neurology. 1994 Aug;44(8):1511-3.
Beta 2-adrenergic agonist as adjunct therapy to levodopa in Parkinson’s disease.
Alexander GM1, Schwartzman RJ, Nukes TA, Grothusen JR, Hooker MD.
We studied the effect of the beta 2-adrenergic agonist albuterol on Parkinson’s disease (PD) patients receiving chronic levodopa treatment. The albuterol-treated patients demonstrated reduced parkinsonian symptoms and an increased ability to tap their index finger between two points 20 cm apart, and were able to perform a “walk test” in 70% of their control time. Three patients currently on chronic albuterol therapy still show amelioration of their parkinsonian symptoms, and two have reduced their daily levodopa dose. This study suggests that beta 2-adrenergic agonists as adjunct therapy to levodopa may be beneficial in PD.
[Indexed for MEDLINE]
“use of β2-agonists is associated with a decreased risk of PD. “© 2018 International Parkinson and Movement Disorder Society.
β2-adrenoceptor agonists and antagonists and risk of Parkinson’s disease.
Potential Benefits of Therapeutic Use of β2-Adrenergic Receptor Agonists in Neuroprotection and Parkinson’s Disease
β2-Adrenergic Agonists for Parkinson’s Disease: Repurposing …
www.brainimmune.com › beta-adrenergic-agonists-parkinsons-disease
by S Mittal – Related articles
Dec 2, 2017 – β2-Adrenergic Agonists and Parkinson’s Disease: New evidence … Edwards DJ, Sorisio DA, Knopf S. Effects of the beta 2-adrenoceptor …
The Role of β-Adrenergic Blockers in Parkinson’s Disease …
https://journals.sagepub.com › doi
May 21, 2013 – Keywords β-adrenergic blocker, Parkinson’s disease, tremor, … These findings suggest that β-adrenergic blockers might affect PD via the …
Use of β2-adrenoreceptor agonist and antagonist … – Neurology
https://n.neurology.org › 2019/05/24 › WNL.0000000000007694.full.pdf
May 24, 2019 – (OR 0.78, 95% CI 0.59–1.02) or inhaled anticholinergics (OR 0.41, 95% CI 0.25–0.67) were … The etiopathogenesis of sporadic Parkinson disease (PD), … these far-reaching health consequences, we sought to replicate.
Parkinson’s and the Beta2-Adrenoreceptor Agonist in Asthma …
https://www.cureparkinsons.org.uk › parkinsons-and-asthma-medication
Researchers have found that compounds in certain drugs used in the treatment of asthma, may also have beneficial effects in Parkinson’s disease.
https://www.michaeljfox.org/news/ask-md-head-trauma-and-parkinsons-disease Muhammed Ali and head trauma and Parkinson’s…
Intent on understanding his condition, Fox grilled various neurologists for information—and an explanation. Could he have contracted it from a head injury he got playing hockey as a kid in Canada? How about the time he blacked out doing a stunt in a film?
People who have been diagnosed with a mild concussion, or mild traumatic brain injury, may have a 56 percent increased risk of developing Parkinson’s disease, according to a study published in the April 18, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.Apr 18, 2018
When Alda was seven years old, he contracted polio. Myocarditis in polio- https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.15.5.735 Dogoxin raises blood pressure-and is used sometimes for myocarditis…So-polio caused lowering of Aurum-digoxin treats that in heart…Low Aurum is symptom of Parkinson’s…Raise Aurum for Parkinson’s?
Higher brain extracellular potassium is associated with brain …
https://www.ncbi.nlm.nih.gov › pmc › articles › PMC4229847
by AP Antunes – 2014 – Cited by 23 – Related articles
Jump to Material and methods – Elevated brain potassium levels ([K+]) are associated with neuronal damage in experimental models. The role of brain extracellular [K+] in patients with poor-grade aneurysmal subarachnoid hemorrhage (aSAH) and its association with hemorrhage load, metabolic dysfunction and outcome has not been studied so far.
Abstract · Introduction · Results · Discussion
Michael J. Fox-hockey head injury
Muhammed Ali-boxing head injuries
Alan Alda, injury due to polio
Dad-hit by streetcar at age 8
all have low Aurum, high Potassium…And Parkinson’s disease…
Beta Adrenergic Agonists raise Aurum…
is one of the most characteristic adverse effects following
administration of β(2)-adrenergic agonists. It is reported by around
2-4% of patients with asthma taking a regular β(2)-adrenergic agonist
and is induced by both short-acting and long-acting agents.
Tremor and β 2-adrenergic agents: Is it a real clinical problem …
https://www.researchgate.net › publication › 51973286_Tremor_and_b_2-a…
a Known: Head injury causes LOSS of Aurum, and HIGH Potassium…
Int J Neurosci. 2016;126(7):630-6. doi: 10.3109/00207454.2015.1051046. Epub 2015 Aug 18.
Reduced plasma taurine level in Parkinson’s disease: association with motor severity and levodopa treatment.
Neuroprotection with Taurine in a Parkinson’s Model System …
https://journeywithparkinsons.com › 2018/04/05 › neuroprotection-with-ta…
Apr 5, 2018 – Taurine protects dopaminergic neurons in a mouse Parkinson’s disease model through inhibition of microglial M1 polarization: Here are some …
Levodopa on Decrease of Plasma Taurine Level in Parkinson’s
https://www.ukessays.com › essays › sciences › levodopa-decrease-plasma-…
Apr 9, 2018 – Title: Levodopa aggravates the decrease of plasma taurine level in Parkinson Disease. Key words: Parkinson’s disease (PD); Oxidative stress; …
Reduced plasma taurine level in Parkinson’s disease …
https://www.tandfonline.com › doi › full
by L Zhang – 2016 – Cited by 15 – Related articles
Aug 20, 2015 – Purpose: This study aimed to evaluate the level of taurine in plasma, and its association with the severity of motor and non-motor symptoms …
Hereditary Mental Depression and Parkinsonism With Taurine Deficiency
Thomas L. Perry, MD; Paul J. A. Bratty, MD, FRCP (C); Shirley Hansen; et al Janet Kennedy; Nadine Urquhart, PhD; Clarisse L. Dolman, MD, FRCP (C)
Arch Neurol. 1975;32(2):108-113. doi:10.1001/archneur.1975.00490440058009
https://bodynutrition.org/taurine/ Best taurine supplements 2020
one of the animal models of Parkinson’s disease is generated by
treating rodents with the complex I inhibitor, rotenone (Cannon et al.,
2009). Taurine deficiency and rotenone actions are similar, as both lead
to reductions in complex I activity, inhibition of NADH dehydrogenase
activity, reductions in respiratory activity and elevations in NADH.
Because a primary physiological function of taurine is the maintenance
of complex I activity, there is reason to believe that taurine therapy
should reduce the severity of Parkinson’s disease (Alkholifi et al.,
2015). Indeed, it has recently been reported that reduced plasma taurine
content is associated with motor severity in Parkinson’s disease (Zhang
et al., 2016). Moreover, a single blind, randomized, controlled study
of 47 patients with Parkinson’s disease revealed effectiveness in
reducing excessive sleepiness upon treatment with the taurine analog,
homotaurine (Ricciardi et al., 2015).
ursodiol(drug form taurine)*
creatine, glutamine, taurine mix, selenium , Omega 3.
serotonin causing tremors, muscle rigidity…